ALZN Alzamend Neuro, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$1.53
Price · Aug 19, 2026
Fundamentals as of Jul 22, 2026

ALZN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.53
Market Cap
$7M
P/E (TTM)
-0.6
EPS (TTM)
$-2.63
Revenue (TTM)
Div Yield
ROE
-598.1%
Debt/Equity
52W Range
$1 – $3

ALZN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-2.63
5-point trend, -1778.6%
2022-04-30 2026-04-30
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ALZN
Peer Median
P/E (TTM)
5-point trend, +100.0%
-0.6
P/B
5-point trend, -99.9%
8.9
1.2

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ALZN
Peer Median
ROA
5-point trend, -85.1%
-262.6%
-130.8%
ROE
5-point trend, -512.4%
-598.1%
-192.5%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ALZN
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ALZN
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ALZN
Peer Median
EPS (Diluted)
5-point trend, -1778.6%
$-2.63

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ALZN
Peer Median

ALZN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-15
Median target $25.00 +1534.0%
Mean target $25.00 +1534.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.75%
Next Report
Sep 08, 2026
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.47 $-0.68 0.21%
March 31, 2026 $-0.58 $-1.96 1.4%
Dec. 31, 2025 $-0.30 $-1.99 1.7%
Sept. 30, 2025 $-1.28 $-0.70 -0.58%
March 31, 2025 $-0.30 $-1.99 1.7%
Dec. 31, 2024 $-3.42 $-3.49 0.07%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ALZN $5M -0.4 -598.1%
AKTX $26.17B -64.1%
AQB $4M -0.2 -21.2% -315.5%
FBLG -0.5
ERNA
ENSC $4M -0.2 -2.8% -200.9% -294.0%
BOLT $11M -0.3 0.07% -433.7% -102.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for ALZN
Metric Trend 2026202520242023202220212020
R&D Expense 7-point trend, +239.4% $4M $1M $6M $7M $5M $1M $1M
SG&A Expense 7-point trend, +53.1% $5M $3M $3M $7M $7M $4M $3M
Operating Expenses 7-point trend, +98.2% $9M $4M $10M $15M $12M $5M $4M
Operating Income 7-point trend, -98.2% $-9M $-4M $-10M $-15M $-12M $-5M $-4M
Interest Expense 6-point trend, -95.4% $6.6K $18.0K $10.1K $7.7K $46.5K $142.4K ·
Interest Income $1.1K · · · · · ·
Other Non-op 7-point trend, -139.8% $-5.5K $-18.0K $-10.1K $-7.7K $-42.5K $-94.7K $13.9K
Pretax Income 7-point trend, -98.9% $-9M $-5M $-10M $-15M $-12M $-5M $-4M
Net Income 7-point trend, -98.9% $-9M $-5M $-10M $-15M $-12M $-5M $-4M
EPS (Basic) 5-point trend, -1778.6% $-2.63 $-11.32 $-132.33 $-22.89 $-0.14 · ·
EPS (Diluted) 5-point trend, -1778.6% $-2.63 $-11.32 $-132.33 $-22.89 $-0.14 · ·
Shares (Basic) 6-point trend, -95.4% 3,337,143 450,799 74,174 650,126 89,095,274 72,650,073 ·
Shares (Diluted) 5-point trend, -96.3% 3,337,143 450,799 74,174 650,126 89,095,274 · ·
EBITDA 6-point trend, -77.0% $-9M $-4M $-10M $-15M $-12M $-5M ·
Balance Sheet 16
Annual Balance Sheet data for ALZN
Metric Trend 2026202520242023202220212020
Cash & Equivalents 7-point trend, +687.2% $710.7K $4M $376.0K $5M $14M $2M $90.3K
Prepaid Expense 7-point trend, -35.1% $1M $228.7K $79.2K $447.6K $349.7K $983.3K $2M
Current Assets 7-point trend, -2.7% $2M $4M $455.2K $6M $14M $3M $2M
PP&E (Net) 5-point trend, +206.0% $314.9K $425.6K $176.3K $79.8K $102.9K · ·
Total Assets 7-point trend, +14.6% $2M $5M $631.6K $6M $15M $3M $2M
Accounts Payable 7-point trend, +44.8% $1M $634.8K $3M $3M $1M $503.6K $929.6K
Short-term Debt · · $300.7K · · · ·
Current Liabilities 4-point trend, +189.2% · · · $3M $1M $899.6K $992.3K
Total Liabilities 6-point trend, +49.6% $1M $634.8K $3M $3M $1M $899.6K ·
Total Debt · · $300.7K · · · ·
Common Stock 7-point trend, -93.4% $425 $78 $8 $65 $9.5K $6.7K $6.5K
Paid-in Capital 7-point trend, +146.7% $68M $63M $51M $62M $57M $34M $28M
Retained Earnings 7-point trend, -471.1% $-67M $-59M $-54M $-44M $-29M $-17M $-12M
Stockholders' Equity 7-point trend, -10.8% $733.2K $4M $-3M $3M $13M $2M $821.7K
Liabilities + Equity 7-point trend, +14.6% $2M $5M $631.6K $6M $15M $3M $2M
Shares Outstanding 7-point trend, -93.4% 4,256,039 778,733 76,444 646,267 95,481,790 67,429,525 64,762,858
Cash Flow 7
Annual Cash Flow data for ALZN
Metric Trend 2026202520242023202220212020
Stock-based Comp 7-point trend, -60.7% $707.5K $325.1K $955.6K $4M $4M $2M $2M
Operating Cash Flow 7-point trend, -243.9% $-8M $-7M $-8M $-9M $-7M $-3M $-2M
Investing Cash Flow 5-point trend, -385.7% · $-300.0K $-147.2K · $-106.5K $100.9K $105.0K
Stock Issued 6-point trend, -65.3% $794.8K $3M $1M · $6M $2M $2M
Net Stock Activity 5-point trend, -62.2% $794.8K $3M $1M · $6M $2M ·
Financing Cash Flow 7-point trend, +111.1% $5M $10M $4M $200 $19M $4M $2M
Taxes Paid $1.1K · · · · · ·
Profitability 6
Annual Profitability data for ALZN
Metric Trend 2026202520242023202220212020
Operating Margin · · · · · -290263.1% ·
Net Margin · · · · · -295812.8% ·
Pretax Margin · · · · · -295812.8% ·
EBITDA Margin · · · · · -290263.1% ·
ROA 6-point trend, -23.0% -262.6% -172.5% -303.9% -145.6% -141.9% -213.5% ·
ROE 6-point trend, +57.5% -598.1% -121.7% 735.0% -251.5% -97.7% -1407.7% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for ALZN
Metric Trend 2026202520242023202220212020
Current Ratio 3-point trend, -37.2% · · · 2.0 12.4 3.2 ·
Quick Ratio 3-point trend, -16.5% · · · 1.8 12.1 2.1 ·
Debt / Equity · · -0.1 · · · ·
Interest Coverage 6-point trend, -3709.4% -1324.5 -249.4 -983.8 -1931.0 -264.8 -34.8 ·
Efficiency 1
Annual Efficiency data for ALZN
Metric Trend 2026202520242023202220212020
Asset Turnover · · · · · 0.0 ·
Per Share 4
Annual Per Share data for ALZN
Metric Trend 2026202520242023202220212020
Book Value / Share 6-point trend, +476.3% $0.17 $5.10 $-3.77 $0.03 $0.14 $0.03 ·
Cash Flow / Share 4-point trend, -2542.2% $-2.42 $-14.57 $-12.22 $-0.09 · · ·
Cash / Share 6-point trend, +483.9% $0.17 $5.07 $0.55 $0.05 $0.15 $0.03 ·
EPS (TTM) 5-point trend, -1778.6% $-2.63 $-11.32 $-132.33 $-22.89 $-0.14 · ·
Growth Rates 1
Annual Growth Rates data for ALZN
Metric Trend 2026202520242023202220212020
Revenue YoY · · · · · -87.8% ·
Valuation (TTM) 10
Annual Valuation (TTM) data for ALZN
Metric Trend 2026202520242023202220212020
Revenue TTM · · · · · $1.7K ·
Net Income TTM 6-point trend, -73.8% $-9M $-5M $-10M $-15M $-12M $-5M ·
Market Cap 5-point trend, -100.0% $5M $5M $44M $71.59B $131.48B · ·
Enterprise Value · · $44M · · · ·
P/E 5-point trend, +100.0% -0.4 -0.5 -0.5 -32.3 -9835.7 · ·
P/B 5-point trend, -99.9% 6.6 1.2 -17.0 23505.3 9847.5 · ·
P / Tangible Book 4-point trend, -99.9% 6.6 1.2 · 23505.3 9847.5 · ·
P / Cash Flow 5-point trend, +100.0% -0.6 -0.7 -5.3 -8022.4 -19878.8 · ·
EV / EBITDA · · -4.4 · · · ·
Earnings Yield 5-point trend, -2306900.0% -230.7% -190.6% -206.8% -3.1% -0.01% · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2026-04-302025-04-302024-04-302023-04-302022-04-30
Net Income $-9M$-5M$-10M$-15M$-12M
Diluted EPS $-2.63$-11.32$-132.33$-22.89$-0.14
Balance Sheet
2026-04-302025-04-302024-04-302023-04-302022-04-30
Debt / Equity -0.1
Current Ratio 2.012.4
Quick Ratio 1.812.1

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 12 filers · $1.7M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (+2 vs prior Q) 3 (0 vs prior Q) 1 (-1 vs prior Q) 3 (+2 vs prior Q) +1.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
KMT WEALTH MANAGEMENT, LLC $1,594,920 1,329,100 95.65% Shares
GEODE CAPITAL MANAGEMENT, LLC $29,530 24,609 1.77% Shares
VANGUARD FIDUCIARY TRUST CO $25,224 21,020 1.51% Shares
VANGUARD CAPITAL MANAGEMENT LLC $9,067 7,556 0.54% Shares
Tower Research Capital LLC (TRC) $4,220 3,517 0.25% Shares
UBS Group AG $2,822 2,352 0.17% Shares
VANGUARD GROUP INC $1,092 600 0.07% Shares
BlackRock, Inc. $524 437 0.03% Shares
IFG Advisory, LLC $26 22 0.00% Shares
SBI Securities Co., Ltd. $26 22 0.00% Shares
Caitong International Asset Management Co., Ltd $4 3 0.00% Shares
HARBOR INVESTMENT ADVISORY, LLC $1 1 0.00% Shares

Company insiders 9 insiders · 2 officers · 8 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Stephan Jackman Chief Executive Officer April 28, 2023 P 45,500 0 0 $0
DAVID J. KATZOFF Chief Financial Officer March 21, 2025 P 5,540 0 0 $0
MILTON C. AULT, III Director July 31, 2026 A 116,648 1 17 $-1,479,528
Hyperscale Data, Inc. Director July 31, 2026 A 0 0 $0
WILLIAM B. HORNE Director Dec. 19, 2025 S 0 0 1 $-7,066
Lynne Fahey Mcgrath Director Oct. 23, 2025 S 25 0 1 $-69
Mark Gustafson Director March 31, 2022 S 60,000 0 0 $0
Andrew H. Woo Director March 15, 2022 M 100,000 0 0 $0
Jeffrey Oram Director March 15, 2022 M 100,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
MILTON C. AULT, III, WILLIAM B. HORNE, HENRY C.W. NISSER, KENNETH S. CRAGUN, DAVID J. KATZOFF, HYPERSCALE DATA, INC., AULT LENDING, LLC, AULT LIFE SCIENCES, INC., AULT LIFE SCIENCES FUND, LLC ×12 filings Oct. 7, 2025 4.40% Amendment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 7,556 SH Aug. 8, 2026 Daily